NEW YORK (GenomeWeb News) – Rosetta Genomics today said that its shareholders have approved a one-for-fifteen reverse stock split, which will take effect before trading opens Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.